SM

Sahil Maheshwari

Active Director Director DIN 10118911
DIN 10118911 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Sahil Maheshwari

Data last updated:

Sahil Maheshwari is a Director at Qualymed Pharma Private Limited (since 2023). Qualymed Pharma Private Limited reported revenue of ₹5.36 Cr (FY 2026).

DIN 10118911
Primary Designation Director
First Appointment 02 May 2023
Oldest Company Age 3 yrs
Largest company Qualymed Pharma Private Limited · ₹5.36 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Qualymed Pharma Private Limited U46497DL2023PTC413542
Director02 May 20232023₹5.36 Cr (FY 2026)Active

Board colleagues of Sahil Maheshwari

NameDINCompanyDesignation
Dinesh Kumar11069195Qualymed Pharma Private LimitedAdditional Director
Sumeet Sood06934358Qualymed Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Qualymed Pharma Private Limited
Premium access

Shareholding and investment profile for Sahil Maheshwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sahil Maheshwari

Sahil Maheshwari currently holds 1 directorship: Qualymed Pharma Private Limited (Director, since 02 May 2023, revenue ₹5.36 Cr (FY 2026)).

Sahil Maheshwari was first appointed on 02 May 2023 as Director at Qualymed Pharma Private Limited.

The current boards of Sahil Maheshwari's companies include Dinesh Kumar (Qualymed Pharma Private Limited), Sumeet Sood (Qualymed Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available